| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | Jan 27, 2025 | X4 Pharmaceuticals, Inc | CFO | Sell | 57.5 | - | 0.00% | ✓ | $33.9K |
| Oct 4, 2024 | Oct 8, 2024 | X4 Pharmaceuticals, Inc | CFO | Sell | 53.8 | - | 0.00% | ✓ | $126.9K |
| Mar 11, 2024 | Mar 11, 2024 | X4 Pharmaceuticals, Inc | CFO | Sell | 13.8 | -52,500 | -100.00% | ✓ | $46.3K |
| Feb 12, 2024 | Feb 12, 2024 | X4 Pharmaceuticals, Inc | CFO | Sell | 13.8 | -27,721 | -34.56% | ✓ | $28K |
| Nov 1, 2023 | Nov 3, 2023 | X4 Pharmaceuticals, Inc | CFO | Sell | 10.0 | -230,645 | -74.19% | ✓ | $168.4K |
| Jun 30, 2023 | Jul 5, 2023 | X4 Pharmaceuticals, Inc | CFO | Sell | 42.5 | -2,641 | -3.19% | ✓ | $5K |
| Jun 23, 2023 | Jun 26, 2023 | X4 Pharmaceuticals, Inc | CFO | Sell | 36.3 | -5,417 | -6.14% | ✓ | $10.5K |
| Jun 15, 2023 | Jun 16, 2023 | X4 Pharmaceuticals, Inc | CFO | Sell | 36.3 | -5,417 | -5.78% | ✓ | $12K |
| Mar 10, 2023 | Mar 13, 2023 | X4 Pharmaceuticals, Inc | CFO | Sell | 13.8 | -52,500 | -35.91% | ✓ | $44.1K |
| Feb 13, 2023 | Feb 15, 2023 | X4 Pharmaceuticals, Inc | CFO | Sell | 23.8 | -27,721 | -15.94% | ✓ | $25.8K |
| Aug 17, 2021 | Aug 19, 2021 | X4 Pharmaceuticals, Inc | CFO | Sell | 28.8 | -10,832 | -8.22% | ✓ | $55.2K |
| Jun 30, 2021 | Jul 1, 2021 | X4 Pharmaceuticals, Inc | CFO | Sell | 48.8 | -2,641 | -1.96% | ✓ | $17.5K |
| Jun 23, 2021 | Jun 25, 2021 | X4 Pharmaceuticals, Inc | CFO | Sell | 86.3 | +10,833 | 8.77% | ✓ | $38K |
| Jun 15, 2021 | Jun 17, 2021 | X4 Pharmaceuticals, Inc | CFO | Sell | 86.3 | +10,833 | 9.61% | ✓ | $42.5K |
| Sep 21, 2020 | Sep 22, 2020 | X4 Pharmaceuticals, Inc | CFO | Sell | 10.0 | -10,834 | -26.80% | ✓ | $76.7K |
| Jun 30, 2020 | Jul 1, 2020 | X4 Pharmaceuticals, Inc | Officer | Sell | 18.8 | -2,641 | -25.00% | ✓ | $24.1K |